Birt-hogg-dubé syndrome is a novel ciliopathy

Human Molecular Genetics

Volumn 22, Issue 21, 2013, Pages 4383-4397

  Luijten, Monique N H ^a   Basten, Sander G ^c   Claessens, Tijs ^a,e   Vernooij, Marigje ^a   Scott, Claire L ^d   Janssen, Renske ^a   Easton, Jennifer A ^a   Kamps, Miriam A F ^a   Vreeburg, Maaike ^b   Broers, Jos L V ^a   Geel, Michel van ^a,b   Menko, Fred H ^f   Harbottle, Richard P ^g   Nookala, Ravi K ^h   Tee, Andrew R ^e   Land, Stephen C ^d   Giles, Rachel H ^c   Coull, Barry J ^a   van Steensel, Maurice A M ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE;

ARTICLE; BIRT HOGG DUBE SYNDROME; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CENTROSOME; CILIOGENESIS; GENE MUTATION; HETEROZYGOTE; KIDNEY CARCINOMA; KIDNEY CELL; KIDNEY CYST; MICROTUBULE; MITOSIS SPINDLE; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WNT SIGNALING PATHWAY;

BASE SEQUENCE; BIRT-HOGG-DUBE SYNDROME; CELL LINE; CELL POLARITY; CELL PROLIFERATION; CENTROSOME; CILIA; HUMANS; KIDNEY; MICROTUBULES; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS; WNT SIGNALING PATHWAY;

EID: 84885692467     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt288     Document Type: Article

References (60)

1. Hornstein, O.P. and Knickenberg, M.(1975) Perifollicular fibromatosis cutis with polyps of the colon-a cutaneo-intestinal syndrome sui generis. Arch. Dermatol. Res., 253, 161-175.
2. Birt, A.R., Hogg, G.R., and Dube, W.J. (1977) Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch. Dermatol., 113, 1674-1677.
3. Houweling, A.C., Gijezen, L.M., Jonker, M.A., van Doorn, M.B., Oldenburg, R.A., van Spaendonck-Zwarts, K.Y., Leter, E.M., van Os, T.A., van Grieken, N.C., Jaspars, E.H. et al. (2011) Renal cancer and pneumothorax risk in Birt-Hogg-Dube syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Br. J. Cancer, 105, 1912-1919.
4. Toro, J.R., Glenn, G., Duray, P., Darling, T., Weirich, G., Zbar, B., Linehan, M., and Turner, M.L. (1999) Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch. Dermatol., 135, 1195-1202.
5. Menko, F.H., van Steensel, M.A., Giraud, S., Friis-Hansen, L., Richard, S., Ungari, S., Nordenskjold, M., Hansen, T.V., Solly, J., and Maher, E.R. (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol., 10, 1199-1206.
6. Kluger, N., Giraud, S., Coupier, I., Avril, M.F., Dereure, O., Guillot, B., Richard, S., and Bessis, D. (2010) Birt-Hogg-Dube syndrome: clinical and genetic studies of 10 French families. Br. J. Dermatol., 162, 527-537.
7. Nickerson, M.L., Warren, M.B., Toro, J.R., Matrosova, V., Glenn, G., Turner, M.L., Duray, P., Merino, M., Choyke, P., Pavlovich, C.P. et al. (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell, 2, 157-164.
8. Hong, S.B., Oh, H., Valera, V.A., Stull, J., Ngo, D.T., Baba, M., Merino, M.J., Linehan, W.M., and Schmidt, L.S. (2010) Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Mol. Cancer, 9, 160.
9. Hudon, V., Sabourin, S., Dydensborg, A.B., Kottis, V., Ghazi, A., Paquet, M., Crosby, K., Pomerleau, V., Uetani, N., and Pause, A. (2010) Renal tumor suppressor function of the Birt-Hogg-Dube syndrome gene product folliculin. J. Med. Genet., 47, 182-189.
10. Baba, M., Hong, S.B., Sharma, N., Warren, M.B., Nickerson, M.L., Iwamatsu, A., Esposito, D., Gillette, W.K., Hopkins, R.F. 3rd, Hartley, J.L. et al. (2006) Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved inAMPKandmTORsignaling. Proc. Natl Acad. Sci. USA, 103, 15552-15557.
11. Baba, M., Furihata, M., Hong, S.B., Tessarollo, L., Haines, D.C., Southon, E., Patel, V., Igarashi, P., Alvord, W.G., Leighty, R. et al. (2008) Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 andAkt-mTORactivation, cell hyperproliferation, and polycystic kidneys. J. Nat. Cancer Inst., 100, 140-154.
12. Hartman, T.R., Nicolas, E., Klein-Szanto, A., Al-Saleem, T., Cash, T.P., Simon, M.C., and Henske, E.P. (2009) The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene, 28, 1594-1604.
13. Hasumi, Y., Baba, M., Ajima, R., Hasumi, H., Valera, V.A., Klein, M.E., Haines, D.C., Merino, M.J., Hong, S.B., Yamaguchi, T.P. et al. (2009) Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc. Natl Acad. Sci. USA, 106, 18722-18727.
14. Preston, R.S., Philp, A., Claessens, T., Gijezen, L., Dydensborg, A.B., Dunlop, E.A., Harper, K.T., Brinkhuizen, T., Menko, F.H., Davies, D.M. et al. (2011) Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene, 30, 1159-1173.
15. Hong, S.B., Oh, H., Valera, V.A., Baba, M., Schmidt, L.S., and Linehan, W.M. (2010) Inactivation of theFLCNtumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS ONE, 5, e15793.
16. Cash, T.P., Gruber, J.J., Hartman, T.R., Henske, E.P., and Simon, M.C. (2011) Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGFbeta-mediated transcription. Oncogene, 30, 2534-2546.
17. Gaur, K., Li, J., Wang, D., Dutta, P., Yan, S.J., Tsurumi, A., Land, H., Wu, G., and Li, W.X. (2013) The Birt-Hogg-Dube tumor suppressor Folliculin negatively regulates ribosomal RNA synthesis. Hum. Mol. Genet., 22, 284-299.
18. Esteban, M.A., Harten, S.K., Tran, M.G., and Maxwell, P.H. (2006) Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J. Am. Soc. Nephrol. JASN, 17, 1801-1806.
19. Hartman, T.R., Liu, D., Zilfou, J.T., Robb, V., Morrison, T., Watnick, T., and Henske, E.P. (2009)The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum. Mol. Genet., 18, 151-163.
20. Ishikawa, H., and Marshall, W.F. (2011) Ciliogenesis: building the cell's antenna. Nat. Rev. Mol. Cell Biol., 12, 222-234.
21. Roy, S. (2009) The motile cilium in development and disease: emerging new insights. BioEssays: News Rev. Mol. Cell. Dev. Biol., 31, 694-699.
22. Patel, V., Li, L., Cobo-Stark, P., Shao, X., Somlo, S., Lin, F., and Igarashi, P. (2008) Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet., 17, 1578-1590.
23. Hildebrandt, F., Benzing, T., and Katsanis, N. (2011) Ciliopathies. N. Engl. J. Med., 364, 1533-1543.
24. Fischer, E., and Pontoglio, M. (2009) Planar cell polarity and cilia. Semin. Cell Dev. Biol., 20, 998-1005.
25. McNeill, H. (2009) Planar cell polarity and the kidney. J. Am. Soc. Nephrol. JASN, 20, 2104-2111.
26. Montani, M., Heinimann, K., von Teichman, A., Rudolph, T., Perren, A., and Moch, H. (2010) VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. Am. J. Surg. Pathol., 34, 806-815.
27. Basten, S.G., Willekers, S., Vermaat, J.S., Slaats, G.G., Voest, E.E., van Diest, P.J., and Giles, R.H. (2013) Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue. Cilia, 2, 2.
28. Kim, J., Dabiri, S., and Seeley, E.S. (2011) Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma. PLoS ONE, 6, e27410.
29. van Asselt, S.J., de Vries, E.G., van Dullemen, H.M., Brouwers, A.H., Walenkamp, A.M., Giles, R.H., and Links, T.P. (2013) Pancreatic cyst development: insights from von Hippel-Lindau disease. Cilia, 2, 3.
30. Bezginov, A., Clark, G.W., Charlebois, R.L., Dar, V.U., and Tillier, E.R. (2013) Coevolution reveals a network of human proteins originating with multicellularity. Mol. Biol. Evol. 30, 332-346.
31. Egeberg, D.L., Lethan, M., Manguso, R., Schneider, L., Awan, A., Jorgensen, T.S., Byskov, A.G., Pedersen, L.B., and Christensen, S.T. (2012) Primary cilia and aberrant cell signaling in epithelial ovarian cancer. Cilia, 1, 15.
32. Menko, F.H., Johannesma, P.C., van Moorselaar, R.J., Reinhard, R., van Waesberghe, J.H., Thunnissen, E., Houweling, A.C., Leter, E.M., Waisfisz, Q., van Doorn, M.B. et al. (2012)Ade novoFLCNmutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation. Familial Cancer, doi:10.1007/s10689-012-9593-8.
33. Kouchi, M., Okimoto, K., Matsumoto, I., Tanaka, K., Yasuba, M., and Hino, O. (2006) Natural history of the Nihon (Bhd gene mutant) rat, a novel model for human Birt-Hogg-Dube syndrome. Virchows Arch., 448, 463-471.
34. Sang, L., Miller, J.J., Corbit, K.C., Giles, R.H., Brauer, M.J., Otto, E.A., Baye, L.M., Wen, X., Scales, S.J., Kwong, M. et al. (2011) Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. Cell, 145, 513-528.
35. Takagi, Y., Kobayashi, T., Shiono, M., Wang, L., Piao, X., Sun, G., Zhang, D., Abe, M., Hagiwara, Y., Takahashi, K. et al. (2008) Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene, 27, 5339-5347.
36. Singh, S.R., Zhen, W., Zheng, Z., Wang, H., Oh, S.W., Liu, W., Zbar, B., Schmidt, L.S., and Hou, S.X. (2006) The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance. Oncogene, 25, 5933-5941.
37. Fisch, C., and Dupuis-Williams, P. (2011) Ultrastructure of cilia and flagella - back to the future! Biol. Cell, 103, 249-270.
38. Adams, N.A., Awadein, A., and Toma, H.S. (2007) The retinal ciliopathies. Ophthalmic Genet., 28, 113-125.
39. Delaval, B., Bright, A., Lawson, N.D., and Doxsey, S. (2011) The cilia protein IFT88 is required for spindle orientation in mitosis. Nat. Cell Biol., 13, 461-468.
40. Wei, C., Bhattaram, V.K., Igwe, J.C., Fleming, E., and Tirnauer, J.S. (2012) The LKB1 tumor suppressor controls spindle orientation and localization of activated AMPK in mitotic epithelial cells. PLoS ONE, 7, e41118.
41. Thoma, C.R., Matov, A., Gutbrodt, K.L., Hoerner, C.R., Smole, Z., Krek, W., and Danuser, G. (2010) Quantitative image analysis identifiespVHLas a key regulator of microtubule dynamic instability. J. Cell Biol., 190, 991-1003.
42. Ryan, M.J., Johnson, G., Kirk, J., Fuerstenberg, S.M., Zager, R.A., and Torok-Storb, B. (1994) HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int., 45, 48-57.
43. Yang, Y., Padilla-Nash, H.M., Vira, M.A., Abu-Asab, M.S., Val, D., Worrell, R., Tsokos, M., Merino, M.J., Pavlovich, C.P., Ried, T. et al. (2008) The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dube gene pathway. Cancer Genet. Cytogenet., 180, 100-109.
44. Lancaster, M.A., Schroth, J., and Gleeson, J.G. (2011) Subcellular spatial regulation of canonical Wnt signalling at the primary cilium. Nat. Cell Biol., 13, 700-707.
45. Lancaster, M.A., and Gleeson, J.G. (2010) Cystic kidney disease: the role of Wnt signaling. Trends Mol. Med., 16, 349-360.
46. Plotnikova, O.V., Golemis, E.A., and Pugacheva, E.N. (2008) Cell cycle-dependent ciliogenesis and cancer. Cancer Res., 68, 2058-2061.
47. MacDonald, B.T., Tamai, K., and He, X. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell, 17, 9-26.
48. Wallingford, J.B., and Mitchell, B. (2011) Strange as it may seem: the many links between Wnt signaling, planar cell polarity, and cilia. Genes Dev., 25, 201-213.
49. Rookmaaker, M.B., van Gerven, H.A.J.M., Goldschmeding, R., and Boer, W.H. (2012) Solid renal tumors of collecting duct origin in patients on chronic lithium therapy. Clin. Kidney J., 5, 412-415.
50. Hedgepeth, C.M., Conrad, L.J., Zhang, J., Huang, H.C., Lee, V.M.and Klein, P.S. (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol., 185, 82-91.
51. Nookala, R.K., Langemeyer, L., Pacitto, A., Ochoa-Montano, B., Donaldson, J.C., Blaszczyk, B.K., Chirgadze, D.Y., Barr, F.A., Bazan, J.F., and Blundell, T.L. (2012) Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer. Open Biol., 2, 120071.
52. Chua, C.E., Lim, Y.S., and Tang, B.L. (2010) Rab35-a vesicular traffic-regulating small GTPase with actin modulating roles. FEBS Lett., 584, 1-6.
53. Smith, K.R., Kieserman, E.K., Wang, P.I., Basten, S.G., Giles, R.H., Marcotte, E.M., and Wallingford, J.B. (2011) A role for central spindle proteins in cilia structure and function. Cytoskeleton, 68, 112-124.
54. Toro, J.R., Wei, M.H., Glenn, G.M., Weinreich, M., Toure, O., Vocke, C., Turner, M., Choyke, P., Merino, M.J., Pinto, P.A. et al. (2008) BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J. Med. Genet., 45, 321-331.
55. Woodward, E.R., Ricketts, C., Killick, P., Gad, S., Morris, M.R., Kavalier, F., Hodgson, S.V., Giraud, S., Bressac-de Paillerets, B., Chapman, C. et al. (2008) Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. Clin. Cancer Res., 14, 5925-5930.
56. Vocke, C.D., Yang, Y., Pavlovich, C.P., Schmidt, L.S., Nickerson, M.L., Torres-Cabala, C.A., Merino, M.J., Walther, M.M., Zbar, B., and Linehan, W.M. (2005) High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J. Natl Cancer Inst., 97, 931-935.
57. Edelman, E.A., Girirajan, S., Finucane, B., Patel, P.I., Lupski, J.R., Smith, A.C., and Elsea, S.H. (2007) Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clin. Genet., 71, 540-550.
58. Albuquerque, C., Breukel, C., van der Luijt, R., Fidalgo, P., Lage, P., Slors, F.J.M., Leitão, C.N., Fodde, R., and Smits, R. (2002) The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the b-catenin signaling cascade. Hum. Mol. Genet., 11, 1549-1560.
59. Lefievre, L., Nash, K., Mansell, S., Costello, S., Punt, E., Correia, J., Morris, J., Kirkman-Brown, J., Wilson, S.M., Barratt, C.L. et al. (2012) 2-APB-potentiated channels amplify CatSper-induced Ca(2+) signals in human sperm. Biochem. J., 448, 189-200.
60. Hu, J., Dong, A., Fernandez-Ruiz, V., Shan, J., Kawa, M., Martinez-Anso, E., Prieto, J., and Qian, C. (2009) Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res., 69, 6951-6959.